We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
-3.67%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$40.3B
AUM Growth
-$1.82B
(-4.3%)
Cap. Flow
+$332M
Cap. Flow
% of AUM
0.83%
Top 10 Holdings %
Top 10 Hldgs %
25.24%
Holding
2,393
New
237
Increased
785
Reduced
642
Closed
83
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$231M |
| 2 |
Gilead Sciences
GILD
|
+$113M |
| 3 |
PG&E
PCG
|
+$102M |
| 4 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$80.2M |
| 5 |
Allstate
ALL
|
+$64.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$472M |
| 2 |
AbbVie
ABBV
|
+$121M |
| 3 |
iShares MSCI USA Value Factor ETF
VLUE
|
+$69.5M |
| 4 |
Salesforce
CRM
|
+$64.3M |
| 5 |
Home Depot
HD
|
+$62.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.24% |
| 2 | Healthcare | 19.03% |
| 3 | Financials | 13.02% |
| 4 | Consumer Discretionary | 9.39% |
| 5 | Industrials | 7.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Chubb
CB
$140B
| $125M | 0.31% |
688,198
| – | – |
|
|
77
Salesforce
CRM
$134B
| $122M | 0.3% |
850,535
-379,275
| -31% | -$64.3M |
|
|
78
PG&E
PCG
$47.8B
| $122M | 0.3% |
9,735,951
+8,688,233
| +829% | +$102M |
|
79
Intel
INTC
$466B
| $122M | 0.3% |
4,718,178
-787,014
| -14% | -$26.8M |
|
80
MetLife
MET
$61B
| $121M | 0.3% |
1,988,352
+288,489
| +17% | +$18.4M |
|
81
Elevance Health
ELV
$81.9B
| $117M | 0.29% |
257,782
+26,720
| +12% | +$12.8M |
|
82
AstraZeneca
AZN
$263B
| $116M | 0.29% |
1,054,252
-277,994
| -21% | -$35.3M |
|
83
Cigna
CI
$76.6B
| $115M | 0.29% |
415,940
+6,221
| +2% | +$1.75M |
|
84
Newmont
NEM
$98.2B
| $115M | 0.29% |
2,734,881
+217,349
| +9% | +$10.2M |
|
85
Valero Energy
VLO
$89.8B
| $115M | 0.28% |
1,072,260
+263,764
| +33% | +$29M |
|
86
Vertex Pharmaceuticals
VRTX
$121B
| $115M | 0.28% |
395,691
+30,810
| +8% | +$8.86M |
|
87
Amgen
AMGN
$203B
| $114M | 0.28% |
507,554
-6,530
| -1% | -$1.58M |
|
88
State Street Blackstone Senior Loan ETF
SRLN
$5.31B
| $113M | 0.28% |
2,770,000
-160,000
| -5% | -$6.77M |
|
89
CVS Health
CVS
$137B
| $113M | 0.28% |
1,180,426
+30,313
| +3% | +$3M |
|
90
Cisco
CSCO
$450B
| $109M | 0.27% |
2,736,167
+166,838
| +6% | +$7.4M |
|
91
iShares Core S&P 500 ETF
IVV
$876B
| $106M | 0.26% |
294,930
| – | – |
|
92
Fastenal
FAST
$54B
| $105M | 0.26% |
4,545,888
+54,172
| +1% | +$1.37M |
|
93
McKesson
MCK
$98.5B
| $104M | 0.26% |
307,173
-39,724
| -11% | -$13.8M |
|
94
Eversource Energy
ES
$28.2B
| $102M | 0.25% |
1,311,564
-46,891
| -3% | -$4.13M |
|
95
American International
AIG
$41.9B
| $99.1M | 0.25% |
2,087,766
-197,668
| -9% | -$10.4M |
|
96
Intuitive Surgical
ISRG
$121B
| $93.4M | 0.23% |
498,177
+59,215
| +13% | +$12.7M |
|
97
IBM
IBM
$202B
| $93.2M | 0.23% |
784,090
+9,412
| +1% | +$1.24M |
|
98
Medtronic
MDT
$107B
| $88.5M | 0.22% |
1,095,679
-77,444
| -7% | -$6.96M |
|
99
Oracle
ORCL
$331B
| $86M | 0.21% |
1,407,400
-161,846
| -10% | -$11.8M |
|
100
LKQ Corp
LKQ
$6.58B
| $83.9M | 0.21% |
1,779,792
+88,500
| +5% | +$4.63M |
|
Similar funds
SCP
Ensign Peak Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, Ensign Peak Advisors held 2,393 positions worth $40.3B, down 4.3% from $42.1B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Ensign Peak Advisors's Q3 2022 filing shows 237 new, 785 increased, 642 reduced and 83 closed positions. Its largest new stake was iShares 1-3 Year Treasury Bond ETF: 975,000 shares worth $79.2M. The largest sale was Visa, an estimated $472M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
- Ensign Peak Advisors's largest Q3 2022 buy was iShares 1-3 Year Treasury Bond ETF: 975,000 shares worth $79.2M.
- Ensign Peak Advisors added most to Mastercard in Q3 2022, an estimated $231M increase.
- Ensign Peak Advisors's biggest Q3 2022 reduction was AbbVie, cutting an estimated $121M.
- Ensign Peak Advisors fully exited Visa in Q3 2022, selling an estimated $472M.
- Ensign Peak Advisors's ten largest holdings make up 25% of its $40.3B portfolio in Q3 2022.
- Ensign Peak Advisors opened 237 new positions and closed 83 in Q3 2022.
- Ensign Peak Advisors's portfolio value fell 4.3% quarter-over-quarter to $40.3B.
Based on Ensign Peak Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.